Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation

Cardiovascular Pathology

Volumn 19, Issue 3, 2010, Pages

  Bukowska, Alicja ^b   Röcken, Christoph ^a   Erxleben, Michaela ^b   Röhl, Friedrich Wilhelm ^b   Hammwöhner, Matthias ^b   Huth, Christof ^c   Ebert, Matthias P A ^e   Lendeckel, Uwe ^d   Goette, Andreas ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Arrhythmia; Diabetes mellitus; Fibrillation; Gender; Nitric oxide; Stroke

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RISK FACTOR; SEX DIFFERENCE; THROMBOEMBOLISM; TISSUE MICROARRAY; UPREGULATION; WESTERN BLOTTING;

AGED; ATRIAL FIBRILLATION; BLOTTING, WESTERN; DIABETES MELLITUS; ENDOCARDIUM; ENDOTHELIUM, VASCULAR; FEMALE; HEART ATRIA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; TISSUE ARRAY ANALYSIS;

EID: 77951879565     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carpath.2008.12.014     Document Type: Article

References (37)

1. Brand F.N., Abbott R.D., Kannel W.B., and Wolf P.A. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA 254 (1985) 3449-3453
2. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 342 (1993) 1255-1262
3. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 415 (2002) 219-226
4. Goette A., Honeycutt C., and Langberg J.J. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 94 (1996) 2968-2974
5. Ausma J., Wijffels M., Thone F., Wouters L., Allessie M., and Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 96 (1997) 3157-3163
6. Fatkin D., Kuchar D.L., Thorburn C.W., and Feneley M.P. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications. J Am Coll Cardiol 23 (1994) 307-316
7. Manning W.J., Silverman D.I., Katz S.E., Riley M.F., Come P.C., Doherty R.M., Munson J.T., and Douglas P.S. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 23 (1994) 1535-1540
8. Kumagai K., Fukunami M., Ohmori M., Kitabatake A., Kamada T., and Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 16 (1990) 377-380
9. Sohara H., Amitani S., Kurose M., and Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 29 (1997) 106-112
10. Goette A., Ittenson A., Hoffmanns P., Reek S., Hartung W., Klein H., Ansorge S., and Geller J.C. Increased expression of P-selectin in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol 23 (2000) 1872-1875
11. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 43 (2004) 2075-2082
12. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., and Van Wagoner D.R. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
13. Hammwöhner M., Ittenson A., Dierkes J., Bukowska A., Lendeckel U., Klein H.U., and Goette A. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation. Exp Biol Med 232 (2007) 581-589
14. Gawaz M., Neumann F.J., Dickfeld T., Koch W., Laugwitz K.L., Adelsberger H., Langenbrink K., Page S., Neumeier D., Schomig A., and Brand K. Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation 98 (1998) 1164-1171
15. Cai H., Li Z., Goette A., Mera F., Honeycutt C., Feterik K., Wilcox J.N., Dudley Jr. S.C., Harrison D.G., and Langberg J.J. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 106 (2002) 2854-2858
16. Dudley Jr. S.C., Hoch N.E., McCann L.A., Honeycutt C., Diamandopoulos L., Fukai T., Harrison D.G., Dikalov S.I., and Langberg J. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 112 (2005) 1266-1273
17. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., and Bauer J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
18. Bukowska A., Lendeckel U., Hirte D., Wolke C., Striggow F., Rohnert P., Huth C., Klein H.U., and Goette A. Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation. Cell Mol Life Sci 63 (2006) 333-342
19. Goette A., Erxleben M., Bukowska A., Pfeiffenberger J., Strugala D., Klein H.U., Huth C., Lendeckel U., and Röcken C. Angiotensin II receptor blockade reduces tachycardia-induced adhesion molecule expression in fibrillating atria. Heart Rhythm 4 5S (2007) S71
20. Schild L., Bukowska A., Gardemann A., Polczyk P., Keilhoff G., Tager M., Dudley S.C., Klein H.U., Goette A., and Lendeckel U. Rapid pacing of embryoid bodies impairs mitochondrial ATP synthesis by a calcium-dependent mechanism-a model of in vitro differentiated cardiomyocytes to study molecular effects of tachycardia. Biochim Biophys Acta 1762 (2006) 608-615
21. Ferrario C.M., and Strawn W.B. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98 (2006) 121-128
22. Wang H.D., Xu S., Johns D.G., Du Y., Quinn M.T., Cayatte A.J., and Cohen R.A. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 88 (2001) 947-953
23. Kamiyama N. Expression of cell adhesion molecules and the appearance of adherent leukocytes on the left atrial endothelium with atrial fibrillation: rabbit experimental model. Jpn Circ J 62 (1998) 837-843
24. Shiroshita-Takeshita A., Brundel B.J., Lavoie J., and Nattel S. Prednisone prevents atrial fibrillation promotion by atrial tachycardia remodeling in dogs. Cardiovasc Res 69 (2006) 865-875
25. Bedi M., McNamara D., London B., and Schwartzman D. Genetic susceptibility to atrial fibrillation in patients with congestive heart failure. Heart Rhythm 3 (2006) 808-812
26. Gensini F., Padeletti L., Fatini C., Sticchi E., Gensini G.F., and Michelucci A. Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation. Pacing Clin Electrophysiol 26 (2003) 295-298
27. Fukuchi M., Watanabe J., Kumagai K., Katori Y., Baba S., Fukuda K., Yagi T., Iguchi A., Yokoyama H., Miura M., Kagaya Y., Sato S., Tabayashi K., and Shirato K. Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol 37 (2001) 1436-1442
28. Wölkart G., Stessel H., Saad Z., Kirchengast M., and Brunner F. Cardioprotective effects of atrasentan, an endothelin-A receptor antagonist, but not of nitric oxide in diabetic mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Br J Pharmacol 148 (2006) 671-681
29. Smith J.M., Sondgeroth K.B., and Wahler G.M. Inhibition of nitric oxide synthase enhances contractile response of ventricular myocytes from streptozotocin-diabetic rats. Mol Cell Biochem 300 (2007) 129-137
30. Brunner F., Andrew P., Wölkart G., Zechner R., and Mayer B. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation 104 (2001) 3097-3102
31. Esberg L.B., and Ren J. Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes. Diabetologia 46 (2003) 1419-1427
32. Förstermann U., and Münzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113 (2006) 1708-1714
33. Campbell D.J., Woodward M., Chalmers J.P., Colman S.A., Jenkins A.J., Kemp B.E., Neal B.C., Patel A., and MacMahon S.W. Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. Arch Neurol 63 (2006) 60-65
34. Knai A., Nagashima M., Nakamura N., Uno T., Nakayama M., Sano T., Hamada Y., Nakamura J., and Hotta N. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with Type 2 diabetes mellitus. Metabolism 55 (2006) 461-466
35. Yamashita T., Sekiguchi A., Iwasaki Y.K., Sagara K., Hatano S., Iinuma H., Aizawa T., and Fu L.T. Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria. Circulation 108 (2003) 2450-2452
36. Goette A., Staack T., Rocken C., Arndt M., Geller J.C., Huth C., Ansorge S., Klein H.U., and Lendeckel U. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35 (2000) 1669-1677
37. Wei C., Jiang S., Lust J.A., Daly R.C., and McGregor C.G. Genetic expression of endothelial nitric oxide synthase in human atrial myocardium. Mayo Clin Proc 71 (1996) 346-350